Literature DB >> 16101423

Selective neuronal nitric oxide synthase inhibitors.

Erik P Erdal1, Elizabeth A Litzinger, Jiwon Seo, Yaoqiu Zhu, Haitao Ji, Richard B Silverman.   

Abstract

This review includes the non-patent literature up to October 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isozyme). Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compounds that are discussed; structures of these compounds generally are not given. In vitro inhibition constants are given either as IC(50) values or as K(i)values. An IC(50) value, the inhibitor concentration that produces 50% inhibition in the presence of a constant concentration of substrate, is obtained by extrapolation of several rate data points to 50% inhibition. K(i) values are derived from several types of plots that relate the concentration of inhibitor with enzyme velocity in the presence of a variety of substrate concentrations [1]. The K(i) value can be estimated from the IC(50) value [2]. Although the two inhibition constants are related, they are not the same; generally, the reported K(i) values tend to be lower than the IC(50) values. If specifics are desired about how the data were collected, then the reader will have to look in the literature cited. No attempt was made to be exhaustive in citing all references related to specific inhibitors; rather, examples of literature references are given for each inhibitor described.

Mesh:

Substances:

Year:  2005        PMID: 16101423     DOI: 10.2174/1568026054679317

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  22 in total

1.  Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model.

Authors:  Silvia L Delker; Haitao Ji; Huiying Li; Joumana Jamal; Jianguo Fang; Fengtian Xue; Richard B Silverman; Thomas L Poulos
Journal:  J Am Chem Soc       Date:  2010-04-21       Impact factor: 15.419

2.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

3.  NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.

Authors:  Paul Renton; Brenda Green; Shawn Maddaford; Suman Rakhit; John S Andrews
Journal:  ACS Med Chem Lett       Date:  2012-01-30       Impact factor: 4.345

4.  1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.

Authors:  Shawn Maddaford; Paul Renton; Joanne Speed; Subhash C Annedi; Jailall Ramnauth; Suman Rakhit; John Andrews; Gabriela Mladenova; Lisa Majuta; Frank Porreca
Journal:  Bioorg Med Chem Lett       Date:  2011-07-22       Impact factor: 2.823

5.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

Review 6.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

7.  Synthesis and enzymatic evaluation of 2- and 4-aminothiazole-based inhibitors of neuronal nitric oxide synthase.

Authors:  Graham R Lawton; Haitao Ji; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Beilstein J Org Chem       Date:  2009-06-04       Impact factor: 2.883

8.  Nitric oxide synthases activation and inhibition by metallacarborane-cluster-based isoform-specific affectors.

Authors:  Robert Kaplánek; Pavel Martásek; Bohumír Grüner; Satya Panda; Jakub Rak; Bettie Sue Siler Masters; Vladimír Král; Linda J Roman
Journal:  J Med Chem       Date:  2012-11-01       Impact factor: 7.446

9.  L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.

Authors:  Jianguo Fang; Haitao Ji; Graham R Lawton; Fengtian Xue; Linda J Roman; Richard B Silverman
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

10.  Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.

Authors:  Julian M Stewart; Marvin S Medow; Christopher T Minson; Indu Taneja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.